Fundraising FoxViamet Pharmaceuticals Holdings Llc
acquired by Aralez PharmaceuticalsDurham, US · Founded 2011 · Delaware LLC · 1 known investors
Find your way into Viamet Pharmaceuticals Holdings Llc
Sign up to see every warm intro you have to Viamet Pharmaceuticals Holdings Llc
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Viamet Pharmaceuticals Holdings Llc team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Acquired by Aralez Pharmaceuticals October 2016 · $60M ($60 million upfront plus milestone payments) · source ↗
Viamet was a Durham, NC clinical-stage biopharmaceutical company developing metalloenzyme-targeted drugs, notably the antifungal VT-1161 (later oteseconazole).
Founders & leadership
NM
Neil MooreExecutive
RJ
Robert J. Schotzinger, M.D., Ph.D.Named on SEC filing
Board
SD
Steven D. WeinsteinBoard director
RI
KA
Kristopher A. WoodBoard director
AH
Adrian HowdBoard director
DR
SE
S. Edward TorresBoard director
WT
William T. White IIIBoard director
LS
Lauren SilvermanBoard director
JR
James RosenBoard director
AV
Andrew von EschenbachBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$61.6M disclosed across 3 rounds · 2011–2016
▶$12MraisedSep 2016 · 12 investors · OtherRule 506(b)
▶$12MraisedSep 2016 · 12 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Steven D. WeinsteinDirector
- Robert J. Schotzinger, M.D., Ph.D.Executive Officer, Director
- Robert IngramDirector
- Kristopher A. WoodDirector
- Adrian HowdDirector
- Andrew von EschenbachDirector
- Douglas ReedDirector
- Jeffrey EdwardsDirector
- G. Kelly MartinDirector
- S. Edward TorresDirector
- Philip R. TracyDirector
- Offering amount
- $48M
- Amount sold
- $12M
- First sale
- Sep 2016
- Incorporated
- Limited Liability Company, Delaware, 2011
- Federal exemptions
- 06b
▶$10MraisedMar 2014 · 7 investors · OtherRule 506(b)
▶$10MraisedMar 2014 · 7 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- S. Edward TorresDirector
- Neil MooreExecutive Officer
- Richard KatzExecutive Officer
- Kenneth BahkDirector
- James RosenDirector
- Robert J. Schotzinger, M.D., Ph.D.Executive Officer, Director
- Lauren SilvermanDirector
- Douglas ReedDirector
- Andrew von EschenbachDirector
- Offering amount
- $15M
- Amount sold
- $10M
- First sale
- Feb 2014
- Incorporated
- Limited Liability Company, Delaware, 2011
- Federal exemptions
- 06b
▶$39.6MraisedJan 2012 · 11 investors · OtherRule 506(b)
▶$39.6MraisedJan 2012 · 11 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Douglas ReedDirector
- Andrew von EschenbachDirector
- William T. White IIIDirector
- Lauren SilvermanDirector
- Neil MooreExecutive Officer
- Robert J. Schotzinger, M.D., Ph.D.Executive Officer, Director
- James RosenDirector
- S. Edward TorresDirector
- Offering amount
- $39.6M
- Amount sold
- $39.6M
- First sale
- Dec 2011
- Incorporated
- Limited Liability Company, Delaware, 2011
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Viamet Pharmaceuticals Holdings Llc do?
- Viamet was a Durham, NC clinical-stage biopharmaceutical company developing metalloenzyme-targeted drugs, notably the antifungal VT-1161 (later oteseconazole).
- Who are Viamet Pharmaceuticals Holdings Llc's investors?
- Viamet Pharmaceuticals Holdings Llc's investors include Hatteras Venture Partners.
- How much funding has Viamet Pharmaceuticals Holdings Llc raised?
- Viamet Pharmaceuticals Holdings Llc has disclosed $61.6M raised across 3 rounds.
- Who acquired Viamet Pharmaceuticals Holdings Llc?
- Viamet Pharmaceuticals Holdings Llc was acquired by Aralez Pharmaceuticals.
- Where is Viamet Pharmaceuticals Holdings Llc headquartered?
- Viamet Pharmaceuticals Holdings Llc is headquartered in Durham, US.